CN1126999A - 具有催产素拮抗剂活性的肽类化合物 - Google Patents

具有催产素拮抗剂活性的肽类化合物 Download PDF

Info

Publication number
CN1126999A
CN1126999A CN94192763A CN94192763A CN1126999A CN 1126999 A CN1126999 A CN 1126999A CN 94192763 A CN94192763 A CN 94192763A CN 94192763 A CN94192763 A CN 94192763A CN 1126999 A CN1126999 A CN 1126999A
Authority
CN
China
Prior art keywords
peptide
pharmaceutical composition
composition according
peptides
alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN94192763A
Other languages
English (en)
Chinese (zh)
Inventor
C·J·奥莱尔
P·梅林
A·尼尔森
J·特龙纳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferring BV
Original Assignee
Ferring BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring BV filed Critical Ferring BV
Publication of CN1126999A publication Critical patent/CN1126999A/zh
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/16Oxytocins; Vasopressins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CN94192763A 1993-07-13 1994-07-07 具有催产素拮抗剂活性的肽类化合物 Pending CN1126999A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9302414A SE501678C2 (sv) 1993-07-13 1993-07-13 Peptid med oxytocinantagonistaktivitet samt farmaceutisk komposition innehållande nämnda peptid
SE9302414-9 1993-07-13

Publications (1)

Publication Number Publication Date
CN1126999A true CN1126999A (zh) 1996-07-17

Family

ID=20390606

Family Applications (1)

Application Number Title Priority Date Filing Date
CN94192763A Pending CN1126999A (zh) 1993-07-13 1994-07-07 具有催产素拮抗剂活性的肽类化合物

Country Status (16)

Country Link
EP (1) EP0791012A1 (enExample)
JP (1) JPH09502427A (enExample)
KR (1) KR960702848A (enExample)
CN (1) CN1126999A (enExample)
AU (1) AU676071B2 (enExample)
CA (1) CA2163114A1 (enExample)
CZ (1) CZ9896A3 (enExample)
FI (1) FI960119L (enExample)
HU (1) HUT74874A (enExample)
IL (1) IL110267A0 (enExample)
NO (1) NO955059D0 (enExample)
PL (1) PL312568A1 (enExample)
SE (1) SE501678C2 (enExample)
TW (1) TW268009B (enExample)
WO (1) WO1995002609A1 (enExample)
ZA (1) ZA945090B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9604341D0 (sv) * 1996-11-26 1996-11-26 Ferring Bv Hepta-peptide oxytocin analogue
AU2003211011A1 (en) 2002-02-27 2003-09-09 Ferring Bv Intermediates and methods for making heptapeptide oxytocin analogues
CA3001057A1 (en) * 2015-10-06 2017-04-13 Ferring B.V. New methods for making barusiban and its intermediates

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5373089A (en) * 1988-09-02 1994-12-13 Northwestern University Oxytocin antagonist
SE9002384D0 (sv) * 1990-07-09 1990-07-09 Ferring Ab Derivat av baklobshormoner
SE501677C2 (sv) * 1993-06-18 1995-04-10 Ferring Bv Biologiskt aktiva vasopressinanaloger, farmaceutiska preparat innehållande dem samt deras användning för framställning av läkemedel

Also Published As

Publication number Publication date
SE501678C2 (sv) 1995-04-10
CA2163114A1 (en) 1995-01-26
CZ9896A3 (en) 1996-06-12
NO955059L (no) 1995-12-13
AU676071B2 (en) 1997-02-27
WO1995002609A1 (en) 1995-01-26
TW268009B (enExample) 1996-01-11
SE9302414L (sv) 1995-01-14
EP0791012A1 (en) 1997-08-27
KR960702848A (ko) 1996-05-23
IL110267A0 (en) 1994-10-21
NO955059D0 (no) 1995-12-13
AU7240694A (en) 1995-02-13
PL312568A1 (en) 1996-04-29
FI960119A0 (fi) 1996-01-10
ZA945090B (en) 1995-02-22
FI960119A7 (fi) 1996-01-10
HUT74874A (en) 1997-02-28
SE9302414D0 (sv) 1993-07-13
HU9503768D0 (en) 1996-02-28
FI960119L (fi) 1996-01-10
JPH09502427A (ja) 1997-03-11

Similar Documents

Publication Publication Date Title
EP0938496B1 (en) Heptapeptide oxytocin analogues
FI92326C (fi) LHRH:n nonapeptidi- ja dekapeptidianalogeja, jotka ovat käyttökelpoisia LHRH:n antagonisteina
JPH0219397A (ja) アルギニンバソプレシン拮抗剤の新規線形誘導体類
Rivier et al. Gonadotropin-releasing hormone antagonists: novel members of the azaline B family
JP2001523232A (ja) GnRH拮抗物質
WO2018128828A1 (en) Novel hepcidin mimetics and uses thereof
HU199879B (en) Process for producing hexapeptides and pharmaceutical compositions comprising same as active ingredient
SK150196A3 (en) Peptides with immunomodulatory effects, pharmaceutical formulations containing them and their use
CN1126999A (zh) 具有催产素拮抗剂活性的肽类化合物
CA2405704C (en) Bombesin analogs for treatment of cancer
IE59556B1 (en) Therapeutic somatostatin analogs
US6316414B1 (en) Somatostatin analogs for the treatment of cancer
CN1041634C (zh) 催产素拮抗剂及其组合物和用途
EP1198478B1 (en) Somatostatin analogs and their use for the treatment of cancer
CN107955061B (zh) 地加瑞克关键中间体的制备方法
JPH02501224A (ja) ブラジキニン アンタゴニスト ペプチド
JP2714425B2 (ja) ポリペプチド
JPH05508849A (ja) 下垂体後葉ホルモン誘導体
JP2025518754A (ja) グリコシル化環状エンドモルフィン類似体
OA10136A (fr) Dérivés de la sorbine procédé pour la synthèse de ces peptides et compositions pharmaceutiques les contenant
WO2002000688A1 (en) Peptide compound and pharmaceutical compositions and medicines containing the same as the active ingredient
ITMI951293A1 (it) Composti polipeptidici contenenti d-2-alchiltriptofano in grado di promuovere la liberazione dell'ormone della
JPH07116234B2 (ja) 新規ペプチド
ITMI941954A1 (it) "composti polipeptidici contenenti d-2-metiltriptofano aventi attivita'sull'aumento del camp intracellulare"
RU96123301A (ru) НОВЫЕ ОПИОИДНЫЕ АНАЛОГИ ПЕПТИДОВ СО СМЕШАННЫМИ СВОЙСТВАМИ μ-АГОНИСТО/δ-АНТАГОНИСТОВ

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication